We are not discussing whether the product is good
We are discussing the management of the company that purchased the IP to develop and exploit it
The particular aspect of the management that is hard to deal with is the mismatch between their comments and reality
I would not care so much if they said CE is 36 months away and we will need a capital raising as opposed to "it is imminent"...in 2017 ..
- Forums
- ASX - By Stock
- Anyone Left?
OSL
oncosil medical ltd
Add to My Watchlist
14.7%
!
$1.17

We are not discussing whether the product is goodWe are...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.17 |
Change
0.150(14.7%) |
Mkt cap ! $16.49M |
Open | High | Low | Value | Volume |
$1.05 | $1.18 | $1.03 | $45.24K | 41.72K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6975 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 2347 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 6975 | 1.160 |
2 | 12327 | 1.130 |
1 | 5000 | 1.120 |
1 | 7500 | 1.080 |
1 | 15000 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.170 | 2347 | 1 |
1.180 | 272 | 1 |
1.195 | 830 | 1 |
1.200 | 66853 | 4 |
1.230 | 45403 | 2 |
Last trade - 14.56pm 26/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online